Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2-99
SponsorArkansas Children's Hospital Research Institute

About this trial

this study is aiming at learning more about primary ciliary dyskinesia (PCD) and tests that are used to diagnose this condition. One purpose of this study is to measure the level of nitric oxide in the nasal passages and examine how often the results correlate with other tests currently done to make the diagnosis.

Eligibility criteria

Qualifiers

Individuals who are diagnosed with Primary Ciliary Dyskinesia OR

Individuals with abnormal PCD diagnostics (abnormal ciliary biopsy or PCD genetics) OR

Individuals with unexplained bronchiectasis OR

Neonatal respiratory distress

Disqualifiers

Individuals who are unable to understand the requirements of the study.

Individuals (or guardians) who are unwilling to provide consent.

Individuals who are unable to complete the testing

Recent history of sinus surgery (within four weeks) or bloody nose (within one week) of testing (they can be included at a later date)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed